The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Casacol Expectorant SyrupMethoxyphenamine hydrochloride 20 mg/5 ml Guaiphenesin 100 mg/5 ml Sodium Citrate 200 mg/5 ml



Phoenix LabsPA1113/007/001

Main Information

Trade NameCasacol Expectorant SyrupMethoxyphenamine hydrochloride 20 mg/5 ml Guaiphenesin 100 mg/5 ml Sodium Citrate 200 mg/5 ml
Active SubstancesMETHOXYPHENAMINE HYDROCHLORIDE
Sodium citrate
Guaiphenesin
Dosage FormSyrup
Licence HolderPhoenix Labs
Licence NumberPA1113/007/001

Group Information

ATC CodeR05CA Expectorants
R05CA10 combinations

Status

License statusAuthorised
Licence Issued23/05/1979
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back